Compounding Pharmacies Market share to see growth of 5% from 2017 to 2024: Global Market Insights Inc. The medical industry report “Compounding Pharmacies Market Size By Product (Oral, Topical, Rectal, Parenteral, Inhaler, Ophthalmic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Therapeutic Area (Hormone Replacement, Pain Management), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Russia, Poland, Greece, Ukraine, Sweden, Norway, Belgium, Czech Republic, Finland, China, India, Japan, Singapore, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa, Qatar, Kuwait), Application Potential, Price Trends, Competitive Market Share & Forecast, 2017 – 2024�, by Global Market Insights, Inc. says Compounding Pharmacies Market will hold a valuation of more than USD 12 billion by 2024, with an estimated CAGR of 5% over 2017-2024. In an era of consequential transformation in the healthcare delivery, compounding pharmacies market is charting a profitable growth curve. Although a major chunk of pharmacists are involved in drug manufacturing, yet with the advancement of technology compounding has become an integral of pharmacy practice. The expanding geriatric population base along with increasing customized medication requirements subject to alternative doses, flavor, formulations are stimulating the market dynamics. In addition to this, the recent trend toward personalized diagnostic approach is expected to complement the business landscape in the years ahead. With the increasing drug shortage issues and drug failure rates in recent times, compounding pharmacies are anticipated to be the best alternative to address the growing drug demand.
The remarkable expansion of compounding pharmacies market is quite evident from its diversified product landscape which includes oral, rectal, inhaler, ophthalmic, topical, and parenteral. Oral medications procured the largest portion of the market share in 2015, and the trend is likely to continue in the years ahead. Growing individual preference toward consuming medicines in the form of tablets, capsules have significantly propelled the market demand from this domain. Other than oral route, parenteral medications will also witness lucrative growth over 20172024, subject to the benefits associated with its compounding preparations. These intramuscular injections result in quick action to the body due to its localized drug application method. 1|Page
U.S. Compounding Pharmacies Market size, By Product, 2013-2024 (USD Billion)
Browse key industry insights spread across 192 pages with 150 market data tables & 14 figures & charts from this 2017 report Compounding Pharmacies Market in detail along with the table of contents at: https://www.gminsights.com/industry-analysis/compounding-pharmacies-market The prevalence of cardiovascular diseases has significantly risen among the adult population, which is likely to drive compounding pharmacies market. Sedentary lifestyles along with heavy consumption of fat-rich foods have led to a rise of these cardiac diseases, which in a way is stimulating the necessity of compounded medications. As per estimates, this sector accounted for the maximum industry share in 2016, and considering these aforementioned grounds, the trend is likely to continue in the years ahead. Pertaining to the increasing natality rates along with incapability of the commercial medicines to meet up with the customized pediatric formulation requirements, pediatric application will also register considerable revenue for compounding pharmacies market by 2024. Speaking of technology, Japan compounding pharmacies market is highly influenced by the incorporation of hi-tech compounding processes. Adoption of automation in pharmacy compounding, presence of elderly population, and implementation of hightech compounding devices in pharmaceutical sector can be together given the credit for the expansion of the regional market. U.S. being one of the most progressive nations w.r.t healthcare infrastructure accounted for the largest compounding pharmacies industry share in 2016. Subject to the increasing drug deficiency in the country coupled with spreading consumer awareness about compounding medications, U.S. market is anticipated to witness a strong position in the global industry by 2024.
2|Page
Compounding pharmacies market is characterized by some of the restraints such as lack of skilled lab personnel, excessive cost of the process, and issues related to its safety standards. To combat these threats, key market players are undertaking various collaborations to sustain their business position in the global industry. Some of the companies engaged in compounding pharmacies market include B. Braun Medical, PharMEDium, Fresenius Kabi, Village Compounding Pharmacy, and Cantrell Drug Company.
Table of Content of Compounding Pharmacies Market: Chapter 1 1.1
Methodology Methodology 1.1.1
Initial data exploration
1.1.2
Statistical model and forecast
1.1.3
Industry insights and validation
1.1.4
Market definitions and forecast parameters
1.2 Data Sources
Chapter 2 2.1
1.2.1
Secondary
1.2.2
Primary
Executive Summary Compounding pharmacies industry 3600 synopsis, 2013 - 2024 2.1.1
Business trends
2.1.2
Product trends
2.1.3
Application trends
2.1.4
Therapeutic area trends
2.1.5
Regional trends
Chapter 3 Compounding Pharmacies Industry Insights 3.1 Industry segmentation 3|Page
3.2 Industry size and forecast, 2013 – 2024 3.3 Industry ecosystem analysis 3.3.1
Vendor matrix
3.3.2
Distribution channel analysis
3.4 Industry impact forces 3.4.1
Growth drivers 3.4.1.1 Increasing geriatric population and improved longevity 3.4.1.2 Growing acceptance of personalized medicines in U.S. and Europe 3.4.1.3 Increasing drug shortage, worldwide 3.4.1.4 Convenience of using compounded drugs 3.4.1.5 Growing drug failure rate
3.4.2
Industry pitfalls and challenges 3.4.2.1 Lack of skilled lab technicians and pharmacists in developed economies 3.4.2.2 High cost of equipment and maintenance of sterile environment 3.4.2.3 Changing regulatory specifications 3.4.2.4 Consumer perception towards compounded drugs
3.5 Growth potential analysis 3.6 Regulatory landscape 3.6.1
U.S.
3.6.2
Europe
3.6.3
Australia
3.7 Reimbursement landscape 4|Page
3.7.1
U.S.
3.7.2
Europe
3.7.3
Australia
3.8 Cost analysis of compounded medications 3.9 Innovative compounding technologies 3.9.1
Web-based quality management system
3.9.2
Digital tools
3.10 Porter’s Analysis 3.11Competitive Landscape, 2016 3.11.1 Business overview 3.11.2 Strategic Dashboard 3.12 PESTEL Analysis About Global Market Insights: Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Arun Hegde Corporate Sales, USA Global Market Insights, Inc. 5|Page
Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Website: https://www.gminsights.com/
6|Page